Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers

Romanian Journal of Morphology and Embryology

Volumn 49, Issue 2, 2008, Pages 137-148

  Lazǎr, Daniela ^a   Tǎban, Sorina ^a   Raica, M ^a   Sporea, I ^a   Cornianu, Marioara ^a   Goldis A ^a   Vernic, Corina ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Gastric cancer; MVD; Survival; Tumor angiogenesis; VEGF

Indexed keywords

ANTIBODY; CD34 ANTIGEN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PROGNOSIS; STOMACH TUMOR; SURVIVAL; VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIGENS, CD34; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 50849116080     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. FOLKMAN J., Tumor angiogenesis: therapeutic implications, N Engl J Med, 1971, 285(21):1182-1186.
2. FOLKMAN J., COLE P., ZIMMERMAN S., Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment, Ann Surg, 1966, 164(3):491-502.
3. FOLKMAN J., The vascularization of tumors, Sci Am, 1976, 234(5):58-64, 70-73.
4. FOLKMAN J., Anti-angiogenesis: new concept for therapy of solid tumors, Ann Surg, 1972, 175(3):409-416.
5. FOLKMAN J., LONG D. M. JR., BECKER F. F., Growth and metastasis of tumor in organ culture, Cancer, 1963, 16:453-467.
6. DVORAK H. F., SIOUSSAT T. M., BROWN L. F., BERSE B., NAGY J. A., SOTREL A., MANSEAU E. J., VAN DE WATER L., SENGER D. R., Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels, J Exp Med, 1991, 174(5):1275-1278.
7. FERRARA N., HOUCK K., JAKEMAN L., LEUNG D. W., Molecular and biological properties of the vascular endothelial growth factor family of proteins, Endocr Rev, 1992, 13(1):18-32.
8. CONNOLLY D. T., Vascular permeability factor: a unique regulator of blood vessel function, J Cell Biochem, 1991, 47(3):219-223.
9. DVORAK H. F., BROWN L. F., DETMAR M., DVORAK A. M., Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis, Am J Pathol, 1995, 146(5):1029-1039.
10. FERRARA N., DAVIS-SMYTH T., The biology of vascular endothelial growth factor, Endocr Rev, 1997, 18(1):4-25.
11. BREIER G., ALBRECHT U., STERRER S., RISAU W., Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation, Development, 1992, 114(2):521-532.
12. PETERS K. G., DE VRIES C., WILLIAMS L. T., VEGF receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth, Proc Natl Acad Sci USA, 1993, 90(19):8915-8919.
13. GERBER H. P., HILLAN K. J., RYAN A. M., KOWALSKI J., KELLER G. A., RANGELL L., WRIGHT B. D., RADTKE F., AGUET M., FERRARA N., VEGF is required for growth and survival in neonatal mice, Development, 1999, 126(6):1149-1159.
14. OTANI N., MINAMI S., YAMOTO M., SHIKONE T., OTANI H., NISHIYAMA R., OTANI T., NAKANO R., The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy, J Clin Endocrinol Metab, 1999, 84(10):3845-3851.
15. BROWN L. F., BERSE B., JACKMAN R. W., TOGNAZZI K., MANSEAU E. J., DVORAK H. F., SENGER D. R., Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas, Am J Pathol, 1993, 143(5):1255-1262.
16. INOUE M., HAGER J. H., FERRARA N., GERBER H. P., HANAHAN D., VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis, Cancer Cell, 2002, 1(2):193-202.
17. GERBER H. P., KOWALSKI J., SHERMAN D., EBERHARD D. A. FERRARA N., Complete inhibition of rhabdomyosarcoma xenografts growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor, Cancer Res, 2000, 60(22):6253-6258.
18. DE VRIES C., ESCOBEDO J. A., UENO H., HOUCK K., FERRARA N., WILLIAMS L. T., The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor, Science, 1992, 255(5047):989-991.
19. KAIPAINEN A.,KORHONEN J., MUSTONEN T., VAN HINSBERGH V. W., FANG G. H., DUMONT D., BREITMAN M., ALITALO K., Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development, Proc Natl Acad Sci USA, 1995, 92(8):3566-3570.
20. CHANG L., KAIPAINEN A., FOLKMAN J., Lymphangiogenesis new mechanisms, Ann N Y Acad Sci, 2002, 979:111-119.
21. SHWEIKI D., ITIN A., SOFFER D., KESHET E., Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis, Nature, 1992, 359(6398):843-845.
22. LEVY A. P., LEVY N. S., GOLDBERG M. A., Post-transcrip- tional regulation of vascular endothelial growth factor by hypoxia, J Biol Chem, 1996, 271(5):2746-2753.
23. DOR Y., KESHET E., Ischemia-driven angiogenesis, Trends Cardiovasc Med, 1997, 7(8):289-294.
24. FERRARA N., Role of vascular endothelial growth factor in regulation of angiogenesis. In: TEICHER B. A. (ed), Antiangiogenic agents in cancer therapy, Humana Press, New Jersey, 1999, 119.
25. ROBERTS W. G., PALADE G. E., Neovasculature induced by vascular endothelial growth factor is fenestrated, Cancer Res, 1997, 57(4):765-772.
26. DU J. R., JIANG Y., ZHANG Y. M., FU H., Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas, World J Gastroenterol, 2003, 9(7):1604-1606.
27. NIU G., BOWMAN T., HUANG M., SHIVERS S., REINTGEN D., DAUD A., CHANG A., KRAKER A., JOVE R., YU H., Roles of activated Src and Stat3 signaling in melanoma tumor cell growth, Oncogene, 2000, 21(46):7001-7010.
28. WEI D., LE X., ZHENG L., WANG L., FREY J. A., GAO A. C., PENG Z., HUANG S., XIONG H. Q., ABBRUZZESE J. L., XIE K., Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis, Oncogene, 2003, 22(3):319-329.
29. XIE T. X., WEI D., LIU M., GAO A. C., ALI-OSMAN F., SAWAYA R., HUANG S., Stat3 activation regulates the expression of metalloproteinase-2 and tumor invasion and metastasis, Oncogene, 2004, 23(20):3550-3560.
30. HOPPELER H., KAYAR S. R., Capillarity and oxidative capacity of muscles, News Physiol Sci, 1988, 3:113-116.
31. ZHAO Z. S., ZHOU J. L., YAO G. Y., RU G. Q., MA J., RUAN J., Correlative studies on bFGF mRNA and MMP-9 mRNA expressions with microvascular density, progression, and prognosis of gastric carcinomas, World J Gastroenterol, 2005, 11(21):3227-3223.
32. TOMANEK R. J., SCHATTERMAN G. C., Angiogenesis: new insights and therapeutic potential, Anat Rec, 2000, 261(3):126-135.
33. LI J. J., CHEN Y., ZHANG S. M., WU D. Y., WANG Y. P., XIN Y., Pathobiological significance of vascular endothelial growth factor and Maspin expressions in human gastric carcinoma, World J Gastroenterol, 2004, 10(18):2624-2627.
34. SONG Z. J., GONG P., WU Y. E., Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer, World J Gastroenterol, 2000, 8(4):591-595.
35. ARAYA M., TERASHIM M., TAKAGANE A., ABE K., NISHIZUKA S., YONEZAWA H., IRINODA T., NAKAYA T., SAITO K., Microvessel count predicts metastasis and prognosis in patients with gastric cancer, J Surg Oncol, 1997, 65(4):232-236.
36. ERENOGLU C., AKIN M. L., ULUUTKU H., TEZCAN L., YILDIRIM S., BATKIN A., Angiogenesis predicts poor prognosis in gastric carcinoma, Dig Surg, 2000, 17(6):581-586.
37. SHI H., XU J. M., ZHONG N., XIE H. J., Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma, World J Gastroenterol, 2003, 9(7):1421-1426.
38. ADACHI Y., YASUDA K., INOMATA M., SATO K., SHIRAISHI N., KITANO S., Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type, Cancer, 2000, 89(7):1418-1424.
39. SONG Z. Y., WEN S. Q., PENG J. P., HUANG X., QIAN K. D., Significance of vascular endothelial growth factor expression and its correlation with inducible nitric oxide synthase in gastric cancer, World J Gastroenterol, 2004, 10(9):1250-1255.
40. KAKEJI Y., KOGA T., SUMIYOSHI Y., SHIBAHARA K., ODA S., MAEHARA Y., SUGIMACHI K., Clinical significance of vascular endothelial growth factor expression in gastric cancer, J Exp Clin Cancer Res, 2002, 21(1):125-129.
41. KARAYIANNAKIS A. J., SYRIGOS K. N., POLYCHRONIDIS A., ZBAR A., KOURAKLIS G., SIMOPOULOS C., KARATZAS G., Circulating VEGF levels in the serum of gastric cancer patients: correlation with variables, patient survival, and tumor surgery, Ann Surg, 2002, 236(1):37-42.
42. KIMURA H., KONISHI K., NUKUI T., KAJI M., MAEDA K., YABUSHITA K., TSUJI M., MIWA A., Prognostic significance of expression of thymidine phosphorylase and vascular endothelial growth factor in human gastric carcinoma, J Surg Oncol, 2001, 76(1):31-36.
43. MEHARA Y., KABASHIMA A., KOGA T., TOKUNAGA E., TAKEUCHI H., KAKEJI Y., SUGIMACHI K., Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma, Surgery, 2000, 128(3):408-416.
44. OHTA M., KONNO H., TANAKA T., BABA M., KAMIYA K., SYOUJI T., KONDOH K., WATANABE M., TERADA M., NAKAMURA S., The significance of circulating vascular endothelial growth factor (VEGF) protein in gastric, Cancer Lett, 2003, 192(2):215-225
45. POON R. T., FAN S. T., WONG J., Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches, Ann Surg, 2003, 238(1):9-28.
46. DU J. R., JIANG Y., ZHANG Y. M., FU H., Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas, World J Gastroenterol, 2003, 9(7):1604-1606.
47. MAEDA K., CHUNG Y. S., OGAWA Y., TAKATSUKA S., KANG S. M., OGAWA M., SAWADA T., SOWA M., Prognostic value of vascular endothelial growth factor expression in gastric carcinoma, Cancer, 1996, 77(5):858-863.
48. HINODA Y., SASAKI S., ISHIDA T., IMAI K., Monoclonal antibodies as effective therapeutic agents for solid tumors, Cancer Sci, 2004, 95(8):621-625.
49. SCAPPATICCI F. A., Mechanism and future directions angiogenesis-based cancer therapies, J Clin Oncol, 2002, 20(18):3906-3927.
50. FERNANDO N. H., HURWITZ H. I., Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer, Semin Oncol, 2003, 30(3 Suppl 6):39-50.
51. HAHM K. B., LIM H. Y., SOHN S., KWON H. J., LEE K. M., LEE J. S., SURH Y. J., KIM Y. B., JOO H. J., KIM W. S., CHO S. W., In vitro evidence of the role of COX-2 in attenuating gastric inflammation and promoting gastric carcinogenesis, J Environ Pathol Toxicol Oncol, 2002, 21(2):165-176.
52. WARREN R. S., YUAN H., MATLI M. R., GILLETT N. A., FERRARA N., Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis, J Clin Invest, 1995, 95(4):1789-1797.
53. BORGSTRÖM P., HILLIAN K. J., SRIRAMARAO P., FERRARA N., Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts for angiostatic therapy from intravital videomicroscopy, Cancer Res, 1996, 56(17):4032-4039.
54. WANG G., DONG Z., XU G., YANG Z., SHOU C., WANG N., LIU T., The effect of antibody against vascular endothelial growth factor on tumor growth and metastasis, J Cancer Res Clin Oncol, 1998, 124(11):615-620.
55. TAO H., LIN Y., YIN H., YAO M., Effect of anti-vascular endothelial growth factor antibody on the progression of human gastric cancer orthotopic xenotransplanted into nude mice, Zhonghua Wai Ke Za Zhi, 1999, 37(4):248-250.
56. WANG N., WANG B., WANG Y. J., Effect of vascular endothelial growth factor antibody Avastin on angiogenesis of human gastric cancer growing orthotopically in nude mice, Ai Zeng, 2006, 25(9):1076-1081.
57. JUNG Y. D., MANSFIELD P. F., AKAGI M., TAKEDA A., LIU W., BUCANA C. D., HICKLIN D. J., ELLIS L. M., Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric in a nude mouse model, Eur J Cancer, 2002, 38(8):1133-1140.